SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TFAP2C
|
ENSG00000087510.5 | transcription factor AP-2 gamma |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TFAP2C | hg19_v2_chr20_+_55204351_55204377 | -0.88 | 4.4e-07 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_+_88728189 | 6.00 |
ENST00000416348.1
|
ADIRF
|
adipogenesis regulatory factor |
chr12_-_52914155 | 5.76 |
ENST00000549420.1
ENST00000551275.1 ENST00000546577.1 |
KRT5
|
keratin 5 |
chr8_+_124194875 | 5.25 |
ENST00000522648.1
ENST00000276699.6 |
FAM83A
|
family with sequence similarity 83, member A |
chr12_-_52887034 | 5.20 |
ENST00000330722.6
|
KRT6A
|
keratin 6A |
chr12_-_28123206 | 5.17 |
ENST00000542963.1
ENST00000535992.1 |
PTHLH
|
parathyroid hormone-like hormone |
chr1_-_27286897 | 5.16 |
ENST00000320567.5
|
C1orf172
|
chromosome 1 open reading frame 172 |
chr1_-_209979375 | 5.14 |
ENST00000367021.3
|
IRF6
|
interferon regulatory factor 6 |
chr19_-_54676884 | 4.99 |
ENST00000376591.4
|
TMC4
|
transmembrane channel-like 4 |
chr19_+_39279838 | 4.93 |
ENST00000314980.4
|
LGALS7B
|
lectin, galactoside-binding, soluble, 7B |
chr1_-_209979465 | 4.91 |
ENST00000542854.1
|
IRF6
|
interferon regulatory factor 6 |
chr22_-_37640277 | 4.85 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr19_-_39264072 | 4.80 |
ENST00000599035.1
ENST00000378626.4 |
LGALS7
|
lectin, galactoside-binding, soluble, 7 |
chr16_+_68679193 | 4.76 |
ENST00000581171.1
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
chr1_-_6321035 | 4.60 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
chr3_-_185542817 | 4.48 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr3_-_185542761 | 4.47 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr12_+_122356488 | 4.41 |
ENST00000397454.2
|
WDR66
|
WD repeat domain 66 |
chr19_-_12912657 | 4.36 |
ENST00000301522.2
|
PRDX2
|
peroxiredoxin 2 |
chr1_+_205473720 | 4.35 |
ENST00000429964.2
ENST00000506784.1 ENST00000360066.2 |
CDK18
|
cyclin-dependent kinase 18 |
chr1_+_6484829 | 4.07 |
ENST00000377828.1
|
ESPN
|
espin |
chr19_+_35607166 | 4.01 |
ENST00000604255.1
ENST00000346446.5 ENST00000344013.6 ENST00000603449.1 ENST00000406988.1 ENST00000605550.1 ENST00000604804.1 ENST00000605552.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chr11_+_118401899 | 3.90 |
ENST00000528373.1
ENST00000544878.1 ENST00000354284.4 ENST00000533137.1 ENST00000532762.1 ENST00000526973.1 ENST00000354064.7 ENST00000533102.1 ENST00000313236.5 ENST00000527267.1 ENST00000524725.1 ENST00000533689.1 |
TMEM25
|
transmembrane protein 25 |
chr18_-_28622774 | 3.80 |
ENST00000434452.1
|
DSC3
|
desmocollin 3 |
chr18_-_28681950 | 3.80 |
ENST00000251081.6
|
DSC2
|
desmocollin 2 |
chr15_+_41136586 | 3.76 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr22_-_37640456 | 3.61 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr16_-_68269971 | 3.58 |
ENST00000565858.1
|
ESRP2
|
epithelial splicing regulatory protein 2 |
chrX_+_115567767 | 3.55 |
ENST00000371900.4
|
SLC6A14
|
solute carrier family 6 (amino acid transporter), member 14 |
chr1_-_26680570 | 3.54 |
ENST00000475866.2
|
AIM1L
|
absent in melanoma 1-like |
chr6_-_31846744 | 3.51 |
ENST00000414427.1
ENST00000229729.6 ENST00000375562.4 |
SLC44A4
|
solute carrier family 44, member 4 |
chr19_-_12912601 | 3.51 |
ENST00000334482.5
|
PRDX2
|
peroxiredoxin 2 |
chr19_-_54676846 | 3.49 |
ENST00000301187.4
|
TMC4
|
transmembrane channel-like 4 |
chr19_-_51487071 | 3.49 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
chr19_-_43969796 | 3.46 |
ENST00000244333.3
|
LYPD3
|
LY6/PLAUR domain containing 3 |
chr1_-_1356628 | 3.45 |
ENST00000442470.1
ENST00000537107.1 |
ANKRD65
|
ankyrin repeat domain 65 |
chr17_-_39769005 | 3.44 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
chr2_+_14772810 | 3.35 |
ENST00000295092.2
ENST00000331243.4 |
FAM84A
|
family with sequence similarity 84, member A |
chr16_-_4588469 | 3.33 |
ENST00000588381.1
ENST00000563332.2 |
CDIP1
|
cell death-inducing p53 target 1 |
chr4_+_100737954 | 3.30 |
ENST00000296414.7
ENST00000512369.1 |
DAPP1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides |
chr11_+_130029457 | 3.20 |
ENST00000278742.5
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma) |
chr18_-_28622699 | 3.17 |
ENST00000360428.4
|
DSC3
|
desmocollin 3 |
chr15_-_83953466 | 3.15 |
ENST00000345382.2
|
BNC1
|
basonuclin 1 |
chr1_+_205473784 | 3.11 |
ENST00000478560.1
ENST00000443813.2 |
CDK18
|
cyclin-dependent kinase 18 |
chr19_-_51522955 | 3.10 |
ENST00000358789.3
|
KLK10
|
kallikrein-related peptidase 10 |
chr1_+_36789335 | 3.10 |
ENST00000373137.2
|
RP11-268J15.5
|
RP11-268J15.5 |
chr1_-_6550625 | 3.06 |
ENST00000377725.1
ENST00000340850.5 |
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr3_+_50192833 | 3.04 |
ENST00000426511.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr11_+_46402583 | 3.03 |
ENST00000359803.3
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr19_-_51487282 | 3.02 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
chr1_-_95007193 | 2.98 |
ENST00000370207.4
ENST00000334047.7 |
F3
|
coagulation factor III (thromboplastin, tissue factor) |
chr3_+_122044084 | 2.96 |
ENST00000264474.3
ENST00000479204.1 |
CSTA
|
cystatin A (stefin A) |
chr4_+_153857468 | 2.92 |
ENST00000511601.1
|
FHDC1
|
FH2 domain containing 1 |
chr1_-_182360918 | 2.91 |
ENST00000339526.4
|
GLUL
|
glutamate-ammonia ligase |
chr1_+_2407754 | 2.89 |
ENST00000419816.2
ENST00000378486.3 ENST00000378488.3 ENST00000288766.5 |
PLCH2
|
phospholipase C, eta 2 |
chr6_+_36098262 | 2.84 |
ENST00000373761.6
ENST00000373766.5 |
MAPK13
|
mitogen-activated protein kinase 13 |
chr1_-_1356719 | 2.84 |
ENST00000520296.1
|
ANKRD65
|
ankyrin repeat domain 65 |
chr15_+_41136734 | 2.82 |
ENST00000568580.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr17_-_39684550 | 2.82 |
ENST00000455635.1
ENST00000361566.3 |
KRT19
|
keratin 19 |
chr5_-_131563474 | 2.79 |
ENST00000417528.1
|
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II |
chr16_-_4588762 | 2.75 |
ENST00000562334.1
ENST00000562579.1 ENST00000567695.1 ENST00000563507.1 |
CDIP1
|
cell death-inducing p53 target 1 |
chr3_-_46735132 | 2.74 |
ENST00000415953.1
|
ALS2CL
|
ALS2 C-terminal like |
chr19_-_460996 | 2.70 |
ENST00000264554.6
|
SHC2
|
SHC (Src homology 2 domain containing) transforming protein 2 |
chr17_+_7255208 | 2.66 |
ENST00000333751.3
|
KCTD11
|
potassium channel tetramerization domain containing 11 |
chr19_-_2050852 | 2.66 |
ENST00000541165.1
ENST00000591601.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
chr19_-_51512804 | 2.65 |
ENST00000594211.1
ENST00000376832.4 |
KLK9
|
kallikrein-related peptidase 9 |
chr19_-_12912688 | 2.64 |
ENST00000435703.1
|
PRDX2
|
peroxiredoxin 2 |
chr6_-_35464727 | 2.62 |
ENST00000402886.3
|
TEAD3
|
TEA domain family member 3 |
chr1_-_153363452 | 2.62 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
chr1_+_44401479 | 2.59 |
ENST00000438616.3
|
ARTN
|
artemin |
chr6_-_143266297 | 2.59 |
ENST00000367603.2
|
HIVEP2
|
human immunodeficiency virus type I enhancer binding protein 2 |
chr18_+_33877654 | 2.58 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
chr16_+_29817841 | 2.53 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr2_-_1748214 | 2.52 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
chr16_-_4588391 | 2.51 |
ENST00000586728.1
|
CDIP1
|
cell death-inducing p53 target 1 |
chr6_+_43044003 | 2.49 |
ENST00000230419.4
ENST00000476760.1 ENST00000471863.1 ENST00000349241.2 ENST00000352931.2 ENST00000345201.2 |
PTK7
|
protein tyrosine kinase 7 |
chr11_+_111411384 | 2.48 |
ENST00000375615.3
ENST00000525126.1 ENST00000436913.2 ENST00000533265.1 |
LAYN
|
layilin |
chr19_+_45281118 | 2.47 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
chr16_+_30907927 | 2.46 |
ENST00000279804.2
ENST00000395019.3 |
CTF1
|
cardiotrophin 1 |
chr13_-_20767037 | 2.44 |
ENST00000382848.4
|
GJB2
|
gap junction protein, beta 2, 26kDa |
chr1_-_11714700 | 2.44 |
ENST00000354287.4
|
FBXO2
|
F-box protein 2 |
chr14_+_95078714 | 2.44 |
ENST00000393078.3
ENST00000393080.4 ENST00000467132.1 |
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
chr3_+_50192499 | 2.43 |
ENST00000413852.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr16_+_67562702 | 2.43 |
ENST00000379312.3
ENST00000042381.4 ENST00000540839.3 |
FAM65A
|
family with sequence similarity 65, member A |
chr4_+_2965307 | 2.43 |
ENST00000398051.4
ENST00000503518.2 ENST00000398052.4 ENST00000345167.6 ENST00000504933.1 ENST00000442472.2 |
GRK4
|
G protein-coupled receptor kinase 4 |
chr19_-_51529849 | 2.43 |
ENST00000600362.1
ENST00000453757.3 ENST00000601671.1 |
KLK11
|
kallikrein-related peptidase 11 |
chr3_-_46735155 | 2.42 |
ENST00000318962.4
|
ALS2CL
|
ALS2 C-terminal like |
chr19_-_6720686 | 2.41 |
ENST00000245907.6
|
C3
|
complement component 3 |
chr3_+_50192537 | 2.40 |
ENST00000002829.3
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr4_+_85504075 | 2.40 |
ENST00000295887.5
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 |
chr18_-_43652211 | 2.38 |
ENST00000589328.1
ENST00000409746.5 |
PSTPIP2
|
proline-serine-threonine phosphatase interacting protein 2 |
chr11_-_118134997 | 2.38 |
ENST00000278937.2
|
MPZL2
|
myelin protein zero-like 2 |
chr11_-_118135160 | 2.38 |
ENST00000438295.2
|
MPZL2
|
myelin protein zero-like 2 |
chr11_+_67071050 | 2.37 |
ENST00000376757.5
|
SSH3
|
slingshot protein phosphatase 3 |
chr17_-_5487768 | 2.36 |
ENST00000269280.4
ENST00000345221.3 ENST00000262467.5 |
NLRP1
|
NLR family, pyrin domain containing 1 |
chr9_-_21995300 | 2.34 |
ENST00000498628.2
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
chr19_-_35992780 | 2.34 |
ENST00000593342.1
ENST00000601650.1 ENST00000408915.2 |
DMKN
|
dermokine |
chr1_-_182360498 | 2.33 |
ENST00000417584.2
|
GLUL
|
glutamate-ammonia ligase |
chr8_-_125740514 | 2.32 |
ENST00000325064.5
ENST00000518547.1 |
MTSS1
|
metastasis suppressor 1 |
chr19_-_42947121 | 2.32 |
ENST00000601181.1
|
CXCL17
|
chemokine (C-X-C motif) ligand 17 |
chr11_+_313503 | 2.32 |
ENST00000528780.1
ENST00000328221.5 |
IFITM1
|
interferon induced transmembrane protein 1 |
chr16_-_31146961 | 2.32 |
ENST00000567531.1
|
PRSS8
|
protease, serine, 8 |
chr11_+_67070919 | 2.30 |
ENST00000308127.4
ENST00000308298.7 |
SSH3
|
slingshot protein phosphatase 3 |
chr3_-_128840604 | 2.29 |
ENST00000476465.1
ENST00000315150.5 ENST00000393304.1 ENST00000393308.1 ENST00000393307.1 ENST00000393305.1 |
RAB43
|
RAB43, member RAS oncogene family |
chr14_-_23834411 | 2.27 |
ENST00000429593.2
|
EFS
|
embryonal Fyn-associated substrate |
chr2_-_46385 | 2.26 |
ENST00000327669.4
|
FAM110C
|
family with sequence similarity 110, member C |
chr3_-_12800751 | 2.24 |
ENST00000435218.2
ENST00000435575.1 |
TMEM40
|
transmembrane protein 40 |
chr17_+_7942335 | 2.23 |
ENST00000380183.4
ENST00000572022.1 ENST00000380173.2 |
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
chr19_+_17581253 | 2.22 |
ENST00000252595.7
ENST00000598424.1 |
SLC27A1
|
solute carrier family 27 (fatty acid transporter), member 1 |
chr19_+_8429031 | 2.21 |
ENST00000301455.2
ENST00000541807.1 ENST00000393962.2 |
ANGPTL4
|
angiopoietin-like 4 |
chr4_+_4388805 | 2.21 |
ENST00000504171.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
chr11_-_64612041 | 2.19 |
ENST00000342711.5
|
CDC42BPG
|
CDC42 binding protein kinase gamma (DMPK-like) |
chr1_+_36771946 | 2.19 |
ENST00000373139.2
ENST00000453908.2 ENST00000426732.2 |
SH3D21
|
SH3 domain containing 21 |
chr15_+_78556809 | 2.19 |
ENST00000343789.3
ENST00000394852.3 |
DNAJA4
|
DnaJ (Hsp40) homolog, subfamily A, member 4 |
chr9_-_22009241 | 2.18 |
ENST00000380142.4
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
chr10_+_72972281 | 2.18 |
ENST00000335350.6
|
UNC5B
|
unc-5 homolog B (C. elegans) |
chr5_+_68711209 | 2.17 |
ENST00000512803.1
|
MARVELD2
|
MARVEL domain containing 2 |
chr3_+_50192457 | 2.16 |
ENST00000414301.1
ENST00000450338.1 |
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr1_+_202995611 | 2.16 |
ENST00000367240.2
|
PPFIA4
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 |
chr20_-_18038521 | 2.16 |
ENST00000278780.6
|
OVOL2
|
ovo-like zinc finger 2 |
chr17_+_8339340 | 2.16 |
ENST00000580012.1
|
NDEL1
|
nudE neurodevelopment protein 1-like 1 |
chr17_-_7493390 | 2.13 |
ENST00000538513.2
ENST00000570788.1 ENST00000250055.2 |
SOX15
|
SRY (sex determining region Y)-box 15 |
chr17_-_74582191 | 2.12 |
ENST00000225276.5
|
ST6GALNAC2
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 |
chr22_+_19744226 | 2.11 |
ENST00000332710.4
ENST00000329705.7 ENST00000359500.3 |
TBX1
|
T-box 1 |
chr16_-_4588822 | 2.11 |
ENST00000564828.1
|
CDIP1
|
cell death-inducing p53 target 1 |
chr1_-_17304771 | 2.10 |
ENST00000375534.3
|
MFAP2
|
microfibrillar-associated protein 2 |
chr15_-_45422056 | 2.10 |
ENST00000267803.4
ENST00000559014.1 ENST00000558851.1 ENST00000559988.1 ENST00000558996.1 ENST00000558422.1 ENST00000559226.1 ENST00000558326.1 ENST00000558377.1 ENST00000559644.1 |
DUOXA1
|
dual oxidase maturation factor 1 |
chr11_-_79151695 | 2.09 |
ENST00000278550.7
|
TENM4
|
teneurin transmembrane protein 4 |
chr21_-_42879909 | 2.09 |
ENST00000458356.1
ENST00000398585.3 ENST00000424093.1 |
TMPRSS2
|
transmembrane protease, serine 2 |
chr15_+_69222827 | 2.07 |
ENST00000310673.3
ENST00000448182.3 ENST00000260364.5 |
SPESP1
NOX5
|
sperm equatorial segment protein 1 NADPH oxidase, EF-hand calcium binding domain 5 |
chr20_+_44098346 | 2.06 |
ENST00000372676.3
|
WFDC2
|
WAP four-disulfide core domain 2 |
chr19_-_11689752 | 2.05 |
ENST00000592659.1
ENST00000592828.1 ENST00000218758.5 ENST00000412435.2 |
ACP5
|
acid phosphatase 5, tartrate resistant |
chr4_+_106816592 | 2.03 |
ENST00000379987.2
ENST00000453617.2 ENST00000427316.2 ENST00000514622.1 ENST00000305572.8 |
NPNT
|
nephronectin |
chr8_-_139926236 | 2.03 |
ENST00000303045.6
ENST00000435777.1 |
COL22A1
|
collagen, type XXII, alpha 1 |
chr1_+_19970797 | 2.03 |
ENST00000548815.1
|
NBL1
|
neuroblastoma 1, DAN family BMP antagonist |
chr19_-_43032532 | 2.01 |
ENST00000403461.1
ENST00000352591.5 ENST00000358394.3 ENST00000403444.3 ENST00000308072.4 ENST00000599389.1 ENST00000351134.3 ENST00000161559.6 |
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
chr4_-_57522673 | 1.99 |
ENST00000381255.3
ENST00000317745.7 ENST00000555760.2 ENST00000556614.2 |
HOPX
|
HOP homeobox |
chr21_-_36260980 | 1.98 |
ENST00000344691.4
ENST00000358356.5 |
RUNX1
|
runt-related transcription factor 1 |
chr11_-_568369 | 1.98 |
ENST00000534540.1
ENST00000528245.1 ENST00000500447.1 ENST00000533920.1 |
MIR210HG
|
MIR210 host gene (non-protein coding) |
chr15_+_45422178 | 1.98 |
ENST00000389037.3
ENST00000558322.1 |
DUOX1
|
dual oxidase 1 |
chr10_+_75670862 | 1.97 |
ENST00000446342.1
ENST00000372764.3 ENST00000372762.4 |
PLAU
|
plasminogen activator, urokinase |
chr17_+_7462031 | 1.96 |
ENST00000380535.4
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
chr11_-_94964354 | 1.95 |
ENST00000536441.1
|
SESN3
|
sestrin 3 |
chr12_-_110271178 | 1.94 |
ENST00000261740.2
ENST00000392719.2 ENST00000346520.2 |
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4 |
chr9_+_133320339 | 1.94 |
ENST00000372394.1
ENST00000372393.3 ENST00000422569.1 |
ASS1
|
argininosuccinate synthase 1 |
chr20_+_44098385 | 1.93 |
ENST00000217425.5
ENST00000339946.3 |
WFDC2
|
WAP four-disulfide core domain 2 |
chr20_-_10654639 | 1.92 |
ENST00000254958.5
|
JAG1
|
jagged 1 |
chr11_+_129245796 | 1.92 |
ENST00000281437.4
|
BARX2
|
BARX homeobox 2 |
chr1_+_2398876 | 1.92 |
ENST00000449969.1
|
PLCH2
|
phospholipase C, eta 2 |
chr4_-_119274121 | 1.92 |
ENST00000296498.3
|
PRSS12
|
protease, serine, 12 (neurotrypsin, motopsin) |
chr1_-_6545502 | 1.91 |
ENST00000535355.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr19_+_16222439 | 1.91 |
ENST00000300935.3
|
RAB8A
|
RAB8A, member RAS oncogene family |
chr6_-_10419871 | 1.91 |
ENST00000319516.4
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chr15_+_101420028 | 1.90 |
ENST00000557963.1
ENST00000346623.6 |
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3 |
chr9_+_115913222 | 1.90 |
ENST00000259392.3
|
SLC31A2
|
solute carrier family 31 (copper transporter), member 2 |
chr3_-_183735651 | 1.90 |
ENST00000427120.2
ENST00000392579.2 ENST00000382494.2 ENST00000446941.2 |
ABCC5
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
chr6_+_45389893 | 1.89 |
ENST00000371432.3
|
RUNX2
|
runt-related transcription factor 2 |
chr1_-_50889155 | 1.89 |
ENST00000404795.3
|
DMRTA2
|
DMRT-like family A2 |
chr14_+_24837226 | 1.89 |
ENST00000554050.1
ENST00000554903.1 ENST00000554779.1 ENST00000250373.4 ENST00000553708.1 |
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
chr16_+_56642489 | 1.88 |
ENST00000561491.1
|
MT2A
|
metallothionein 2A |
chr17_-_39677971 | 1.88 |
ENST00000393976.2
|
KRT15
|
keratin 15 |
chr19_-_53324884 | 1.87 |
ENST00000457749.2
ENST00000414252.2 ENST00000391783.2 |
ZNF28
|
zinc finger protein 28 |
chr6_+_30851840 | 1.87 |
ENST00000511510.1
ENST00000376569.3 ENST00000376575.3 ENST00000376570.4 ENST00000446312.1 ENST00000504927.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr14_+_102027688 | 1.86 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
chr19_-_45908292 | 1.86 |
ENST00000360957.5
ENST00000592134.1 |
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like |
chr3_+_3841108 | 1.85 |
ENST00000319331.3
|
LRRN1
|
leucine rich repeat neuronal 1 |
chr19_-_5851442 | 1.85 |
ENST00000458379.2
ENST00000589714.1 ENST00000589918.1 ENST00000303225.6 ENST00000589620.1 |
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) |
chr2_+_14775215 | 1.85 |
ENST00000581929.1
|
AC011897.1
|
Uncharacterized protein |
chr19_+_35645817 | 1.85 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr13_-_107187462 | 1.85 |
ENST00000245323.4
|
EFNB2
|
ephrin-B2 |
chr9_+_133320301 | 1.85 |
ENST00000352480.5
|
ASS1
|
argininosuccinate synthase 1 |
chr17_+_73717516 | 1.85 |
ENST00000200181.3
ENST00000339591.3 |
ITGB4
|
integrin, beta 4 |
chr17_-_4463856 | 1.84 |
ENST00000574584.1
ENST00000381550.3 ENST00000301395.3 |
GGT6
|
gamma-glutamyltransferase 6 |
chr15_+_45422131 | 1.84 |
ENST00000321429.4
|
DUOX1
|
dual oxidase 1 |
chr1_-_209824643 | 1.83 |
ENST00000391911.1
ENST00000415782.1 |
LAMB3
|
laminin, beta 3 |
chr12_-_50677255 | 1.83 |
ENST00000551691.1
ENST00000394943.3 ENST00000341247.4 |
LIMA1
|
LIM domain and actin binding 1 |
chr11_-_119599794 | 1.83 |
ENST00000264025.3
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
chr1_-_6546001 | 1.83 |
ENST00000400913.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr6_-_166796461 | 1.83 |
ENST00000360961.6
ENST00000341756.6 |
MPC1
|
mitochondrial pyruvate carrier 1 |
chr3_-_160823040 | 1.81 |
ENST00000484127.1
ENST00000492353.1 ENST00000473142.1 ENST00000468268.1 ENST00000460353.1 ENST00000320474.4 ENST00000392781.2 |
B3GALNT1
|
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
chr19_-_11450249 | 1.81 |
ENST00000222120.3
|
RAB3D
|
RAB3D, member RAS oncogene family |
chr4_+_89444961 | 1.81 |
ENST00000513325.1
|
HERC3
|
HECT and RLD domain containing E3 ubiquitin protein ligase 3 |
chr12_+_10366016 | 1.81 |
ENST00000546017.1
ENST00000535576.1 ENST00000539170.1 |
GABARAPL1
|
GABA(A) receptor-associated protein like 1 |
chr6_+_7108210 | 1.81 |
ENST00000467782.1
ENST00000334984.6 ENST00000349384.6 |
RREB1
|
ras responsive element binding protein 1 |
chr2_+_47596634 | 1.79 |
ENST00000419334.1
|
EPCAM
|
epithelial cell adhesion molecule |
chr6_+_29691198 | 1.78 |
ENST00000440587.2
ENST00000434407.2 |
HLA-F
|
major histocompatibility complex, class I, F |
chr1_+_180165672 | 1.78 |
ENST00000443059.1
|
QSOX1
|
quiescin Q6 sulfhydryl oxidase 1 |
chr10_+_71078595 | 1.77 |
ENST00000359426.6
|
HK1
|
hexokinase 1 |
chr20_-_3219828 | 1.76 |
ENST00000539553.2
|
SLC4A11
|
solute carrier family 4, sodium borate transporter, member 11 |
chr11_+_35160709 | 1.76 |
ENST00000415148.2
ENST00000433354.2 ENST00000449691.2 ENST00000437706.2 ENST00000360158.4 ENST00000428726.2 ENST00000526669.2 ENST00000433892.2 ENST00000278386.6 ENST00000434472.2 ENST00000352818.4 ENST00000442151.2 |
CD44
|
CD44 molecule (Indian blood group) |
chr16_+_71660079 | 1.75 |
ENST00000565261.1
ENST00000268485.3 ENST00000299952.4 |
MARVELD3
|
MARVEL domain containing 3 |
chr15_+_78556428 | 1.75 |
ENST00000394855.3
ENST00000489435.2 |
DNAJA4
|
DnaJ (Hsp40) homolog, subfamily A, member 4 |
chr11_+_118826999 | 1.74 |
ENST00000264031.2
|
UPK2
|
uroplakin 2 |
chr12_+_70760056 | 1.74 |
ENST00000258111.4
|
KCNMB4
|
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
chr21_-_42880075 | 1.74 |
ENST00000332149.5
|
TMPRSS2
|
transmembrane protease, serine 2 |
chr19_+_45973120 | 1.74 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
chr5_+_68711023 | 1.74 |
ENST00000515844.1
|
MARVELD2
|
MARVEL domain containing 2 |
chr1_+_9242221 | 1.73 |
ENST00000412639.2
|
RP3-510D11.2
|
RP3-510D11.2 |
chr1_+_36772691 | 1.73 |
ENST00000312808.4
ENST00000505871.1 |
SH3D21
|
SH3 domain containing 21 |
chr16_-_65155833 | 1.73 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr2_+_27665232 | 1.72 |
ENST00000543753.1
ENST00000288873.3 |
KRTCAP3
|
keratinocyte associated protein 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 10.5 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
1.3 | 5.2 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
1.3 | 1.3 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
1.3 | 5.2 | GO:0051710 | cytolysis by symbiont of host cells(GO:0001897) regulation of cytolysis in other organism(GO:0051710) |
1.2 | 3.7 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
1.2 | 4.8 | GO:0032771 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
1.2 | 3.5 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
1.1 | 3.2 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
1.0 | 3.1 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
1.0 | 5.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.0 | 3.0 | GO:0097195 | pilomotor reflex(GO:0097195) |
1.0 | 3.0 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.0 | 5.8 | GO:0030421 | defecation(GO:0030421) |
1.0 | 2.9 | GO:0060667 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
0.9 | 0.9 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.9 | 2.6 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.8 | 3.2 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.8 | 2.4 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.8 | 2.4 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.8 | 5.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.8 | 8.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.8 | 2.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.8 | 3.8 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.7 | 6.6 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.7 | 2.1 | GO:0048627 | myoblast development(GO:0048627) |
0.7 | 2.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.7 | 8.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.7 | 3.4 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.7 | 2.0 | GO:0043317 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
0.7 | 9.1 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.6 | 1.9 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
0.6 | 3.8 | GO:0042335 | cuticle development(GO:0042335) |
0.6 | 1.9 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.6 | 1.9 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.6 | 11.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.6 | 1.8 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.6 | 0.6 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.6 | 1.8 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
0.6 | 2.3 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.6 | 3.5 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.6 | 1.7 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.5 | 2.1 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) |
0.5 | 1.6 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.5 | 2.1 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.5 | 6.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.5 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.5 | 1.5 | GO:1990709 | maintenance of synapse structure(GO:0099558) presynaptic active zone organization(GO:1990709) |
0.5 | 1.5 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.5 | 1.5 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
0.5 | 11.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.5 | 1.5 | GO:0060129 | regulation of calcium-independent cell-cell adhesion(GO:0051040) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.5 | 4.9 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.5 | 3.9 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.5 | 2.9 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.5 | 1.4 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.5 | 1.9 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.5 | 1.9 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.5 | 1.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 1.9 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) regulation of centriole elongation(GO:1903722) |
0.4 | 2.7 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
0.4 | 3.5 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.4 | 1.7 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.4 | 3.0 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 5.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.4 | 2.1 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.4 | 0.8 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.4 | 1.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.4 | 4.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.4 | 1.2 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.4 | 1.2 | GO:0015813 | acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
0.4 | 2.0 | GO:0003070 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.4 | 2.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.4 | 13.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.4 | 3.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 2.7 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.4 | 1.9 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 1.9 | GO:0021622 | optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.4 | 1.5 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.4 | 4.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.4 | 1.1 | GO:1904235 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
0.4 | 1.5 | GO:1903232 | melanosome assembly(GO:1903232) |
0.4 | 1.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.4 | 1.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.4 | 2.2 | GO:0060214 | endocardium formation(GO:0060214) |
0.4 | 1.1 | GO:1902565 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.4 | 2.8 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 0.3 | GO:0072221 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric DCT cell differentiation(GO:0072240) |
0.3 | 1.0 | GO:1901207 | regulation of heart looping(GO:1901207) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
0.3 | 1.0 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.3 | 1.7 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 1.0 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.3 | 1.7 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
0.3 | 1.0 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.3 | 2.3 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 1.0 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.3 | 1.6 | GO:2000691 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.3 | 1.9 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.3 | 0.6 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.3 | 1.9 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.3 | 0.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.3 | 0.6 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.3 | 1.8 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 0.9 | GO:0048597 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.3 | 2.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.3 | 0.9 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.3 | 2.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.3 | 0.3 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.3 | 0.9 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.3 | 10.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 0.9 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.3 | 3.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 0.6 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.3 | 2.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 2.0 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.3 | 1.4 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.3 | 1.4 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.3 | 1.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.3 | 1.1 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.3 | 2.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 0.8 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.3 | 1.1 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.3 | 2.8 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.3 | 0.8 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.3 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 1.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 0.8 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
0.3 | 1.4 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
0.3 | 4.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 2.6 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.3 | 0.3 | GO:0002663 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.3 | 1.3 | GO:1904450 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.3 | 1.0 | GO:0035900 | response to isolation stress(GO:0035900) |
0.3 | 3.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 1.0 | GO:1990927 | short-term synaptic potentiation(GO:1990926) calcium ion regulated lysosome exocytosis(GO:1990927) |
0.3 | 0.5 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.3 | 0.8 | GO:0008057 | eye pigment granule organization(GO:0008057) |
0.3 | 0.3 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 0.8 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.2 | 0.7 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.2 | 2.9 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.2 | 1.0 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 1.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.2 | 1.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.9 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.9 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.2 | 0.7 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.2 | 0.9 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.2 | 0.5 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.2 | 1.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.2 | 0.9 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.2 | 2.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 4.5 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 | 3.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.2 | 0.5 | GO:0060070 | canonical Wnt signaling pathway(GO:0060070) |
0.2 | 0.7 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.2 | 1.1 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.2 | 0.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 1.1 | GO:0008050 | female courtship behavior(GO:0008050) |
0.2 | 0.2 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.2 | 0.7 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.2 | 1.7 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 0.2 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.2 | 0.6 | GO:0003294 | atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
0.2 | 0.6 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.2 | 0.9 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 1.3 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.2 | 0.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 0.6 | GO:0035283 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 1.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.2 | 2.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 13.5 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.2 | 0.6 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 3.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 1.8 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.2 | 1.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.2 | 5.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.2 | GO:0010157 | response to chlorate(GO:0010157) |
0.2 | 1.4 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.2 | 2.2 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.2 | 0.4 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.2 | 0.8 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.2 | 2.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 4.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.2 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
0.2 | 3.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 1.9 | GO:0060180 | female mating behavior(GO:0060180) |
0.2 | 0.6 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.2 | 1.4 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 0.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 1.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 0.6 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.2 | 1.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 0.6 | GO:0019827 | stem cell population maintenance(GO:0019827) maintenance of cell number(GO:0098727) |
0.2 | 1.5 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 2.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 1.7 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 3.7 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 1.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 0.6 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.2 | 0.7 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.2 | 0.5 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.2 | 0.5 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.2 | 2.6 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 0.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 3.3 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 0.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.9 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 0.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.2 | 1.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 2.6 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.9 | GO:0016240 | autophagosome docking(GO:0016240) |
0.2 | 0.2 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.2 | 0.2 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 0.7 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.2 | 0.3 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.2 | 1.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 0.2 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.2 | 1.5 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 0.7 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.2 | 1.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.5 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.2 | 0.2 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.2 | 1.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 1.0 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 2.1 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 3.7 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.3 | GO:0021759 | globus pallidus development(GO:0021759) |
0.2 | 0.6 | GO:0006788 | heme oxidation(GO:0006788) |
0.2 | 0.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.2 | 1.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 4.9 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.6 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 1.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 1.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.2 | 0.3 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.2 | 0.6 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.2 | 0.3 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 1.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.2 | 0.6 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.2 | 1.4 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.2 | 0.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 6.5 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.2 | 0.5 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
0.2 | 0.3 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.1 | 1.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 1.6 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 1.6 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.4 | GO:1990785 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) response to water-immersion restraint stress(GO:1990785) |
0.1 | 1.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.6 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
0.1 | 0.7 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 1.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.3 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.4 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 1.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.1 | 1.3 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
0.1 | 1.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.3 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 0.8 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 0.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.7 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.1 | 0.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.7 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 1.0 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.1 | 0.4 | GO:1990637 | response to prolactin(GO:1990637) |
0.1 | 0.3 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.1 | 0.3 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 0.5 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.1 | 2.4 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.5 | GO:0002384 | hepatic immune response(GO:0002384) |
0.1 | 3.0 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.8 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 3.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 1.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.5 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
0.1 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.8 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.1 | 0.9 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 1.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.9 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.9 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.4 | GO:0080121 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.1 | 3.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.6 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 | 1.2 | GO:1905247 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 2.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 17.9 | GO:0070268 | cornification(GO:0070268) |
0.1 | 2.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 1.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 1.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.4 | GO:1901983 | regulation of protein acetylation(GO:1901983) |
0.1 | 2.5 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.9 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.1 | 1.5 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 0.7 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.1 | 0.5 | GO:0000966 | RNA 5'-end processing(GO:0000966) germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.9 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 1.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 2.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.7 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.2 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.1 | 0.9 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.1 | 3.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 1.9 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.4 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.1 | 1.1 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.5 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 1.1 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.1 | 0.4 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.9 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 1.5 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
0.1 | 0.5 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.5 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 2.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.6 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.1 | 0.4 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.1 | 0.4 | GO:1904504 | lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.1 | 0.3 | GO:1903984 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.7 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.1 | 1.1 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.2 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.1 | 0.3 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.1 | 1.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.1 | 0.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.1 | 1.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.9 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.1 | 0.5 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 1.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 1.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.5 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.1 | 0.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.5 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.1 | 0.5 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 7.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.3 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.1 | 1.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 4.4 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.4 | GO:0018277 | protein deamination(GO:0018277) |
0.1 | 0.7 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.1 | 1.6 | GO:0001502 | cartilage condensation(GO:0001502) |
0.1 | 1.5 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.1 | 0.2 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
0.1 | 0.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.2 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
0.1 | 1.3 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.1 | 4.5 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 3.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.5 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.7 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 0.3 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 9.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 1.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.6 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 1.1 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.1 | 0.4 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.1 | 0.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.4 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 1.7 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.6 | GO:0035912 | dorsal aorta morphogenesis(GO:0035912) |
0.1 | 3.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.3 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.1 | 0.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 1.0 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 1.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 1.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.4 | GO:0019860 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) beta-alanine metabolic process(GO:0019482) thymine metabolic process(GO:0019859) uracil metabolic process(GO:0019860) |
0.1 | 0.4 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 1.1 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
0.1 | 0.3 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 1.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 1.5 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.4 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.4 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.1 | 0.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.4 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.9 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) positive regulation of secondary heart field cardioblast proliferation(GO:0072513) regulation of cell proliferation involved in heart morphogenesis(GO:2000136) |
0.1 | 0.6 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.8 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 1.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.9 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 1.0 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.1 | 0.3 | GO:0042247 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.1 | 1.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 2.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.6 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.1 | 0.9 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.1 | 2.5 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 2.4 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 0.2 | GO:0071611 | glial cell-derived neurotrophic factor secretion(GO:0044467) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) positive regulation of granulocyte colony-stimulating factor production(GO:0071657) metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
0.1 | 0.3 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.1 | 0.4 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.1 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.9 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 1.0 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.4 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.9 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.6 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.9 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.5 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.7 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.1 | 1.5 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 1.0 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.3 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.1 | 4.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.9 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.3 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.1 | 1.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.3 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 0.5 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.1 | 0.6 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.1 | 0.4 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.1 | 0.5 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.1 | 0.5 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.4 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.1 | 2.0 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 0.4 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 1.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 1.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 1.0 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.2 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.1 | 1.3 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 1.2 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.1 | 5.6 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.6 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 1.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.3 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.1 | 0.3 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.1 | 1.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 1.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 0.8 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.1 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.1 | 1.1 | GO:0070977 | bone maturation(GO:0070977) |
0.1 | 0.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 | 0.8 | GO:0046959 | habituation(GO:0046959) |
0.1 | 2.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.5 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 1.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 1.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.5 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.1 | 1.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.5 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.2 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
0.1 | 0.5 | GO:0021510 | spinal cord development(GO:0021510) |
0.1 | 6.6 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.5 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 0.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.6 | GO:0051938 | L-glutamate import(GO:0051938) |
0.1 | 0.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.3 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.5 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 1.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.4 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 1.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.8 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 1.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 0.3 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.1 | 0.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.1 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.1 | 0.4 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.3 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.6 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.1 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
0.1 | 1.9 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.2 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.3 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.1 | 4.1 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.4 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 1.8 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.2 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
0.1 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 1.2 | GO:0051412 | response to corticosterone(GO:0051412) |
0.1 | 0.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 1.7 | GO:0042044 | fluid transport(GO:0042044) |
0.1 | 0.6 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.5 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.8 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.1 | 1.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.2 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.3 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 1.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.2 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.1 | 0.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 8.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.7 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.8 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 1.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.3 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.1 | 0.6 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.7 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 5.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 1.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.1 | 1.2 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.2 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.4 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.4 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 0.4 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.1 | 2.3 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.1 | 0.2 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.1 | 0.4 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.1 | 1.2 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.2 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.1 | 0.3 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.1 | 1.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.5 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.1 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
0.1 | 0.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 1.0 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 4.4 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 2.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.2 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.3 | GO:0033383 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) farnesyl diphosphate metabolic process(GO:0045338) |
0.0 | 0.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.0 | 0.2 | GO:0060425 | lung morphogenesis(GO:0060425) |
0.0 | 0.3 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.1 | GO:0061197 | olfactory placode formation(GO:0030910) fungiform papilla morphogenesis(GO:0061197) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.1 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.0 | 0.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.1 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.0 | 0.1 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.0 | 0.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.0 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.1 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.0 | 0.3 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.0 | 0.3 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.0 | 0.1 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.2 | GO:0007613 | memory(GO:0007613) |
0.0 | 0.5 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.0 | 0.3 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.0 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.0 | 0.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.4 | GO:2000467 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.2 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.8 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.0 | 0.7 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.0 | 0.3 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.3 | GO:0035733 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.5 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.0 | 1.9 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.1 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.0 | 0.1 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 1.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.4 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 1.9 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.9 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.2 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 1.0 | GO:0050913 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) sensory perception of bitter taste(GO:0050913) |
0.0 | 0.2 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.0 | 1.0 | GO:0030178 | negative regulation of Wnt signaling pathway(GO:0030178) |
0.0 | 0.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.8 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 1.7 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.1 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
0.0 | 0.7 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.5 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.9 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.2 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
0.0 | 1.4 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.0 | 0.6 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 1.0 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.3 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 1.4 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.0 | 0.1 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.0 | 0.3 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.0 | 0.4 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.0 | 1.7 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.2 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.0 | 0.9 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.1 | GO:0099542 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.0 | 0.1 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.0 | 0.5 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.0 | 1.7 | GO:1903955 | regulation of protein targeting to mitochondrion(GO:1903214) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 1.9 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
0.0 | 1.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.6 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.3 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.1 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.0 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.0 | 1.2 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.0 | 0.3 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.0 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.0 | 1.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.2 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.0 | 0.4 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.0 | 0.0 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.0 | 0.2 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.0 | 0.2 | GO:0035926 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) |
0.0 | 0.2 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
0.0 | 0.5 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.0 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.0 | 0.2 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.4 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.2 | GO:0032445 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.0 | 0.1 | GO:1903541 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.0 | 1.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.1 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.0 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 1.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.1 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.0 | 0.4 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 1.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.5 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.8 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.3 | GO:0046051 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.0 | 0.4 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.3 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.0 | 0.3 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 1.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.6 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.1 | GO:0046833 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
0.0 | 3.7 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.2 | GO:0051918 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.0 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.0 | 0.1 | GO:1902598 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
0.0 | 0.5 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.4 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.2 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) histone H2A K63-linked ubiquitination(GO:0070535) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.1 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.0 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.2 | GO:0030473 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear migration along microfilament(GO:0031022) |
0.0 | 0.2 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.3 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.0 | 0.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 1.4 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.3 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.4 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.1 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.3 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 0.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 1.0 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 1.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.2 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
0.0 | 0.1 | GO:1904530 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
0.0 | 0.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:1902547 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.2 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.3 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.0 | 0.4 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.1 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.0 | 0.5 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.0 | 0.2 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.4 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.2 | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0007178) |
0.0 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.6 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.0 | 0.1 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
0.0 | 0.1 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.0 | 0.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.3 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.0 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.0 | 0.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.2 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.0 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.0 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
0.0 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.2 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.0 | 0.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) transcription factor import into nucleus(GO:0042991) |
0.0 | 0.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.6 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 0.3 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.0 | 0.2 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.0 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.2 | GO:0006547 | histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 1.3 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.0 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.0 | 0.0 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.3 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.2 | GO:0051904 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) pigment granule transport(GO:0051904) establishment of pigment granule localization(GO:0051905) |
0.0 | 0.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.1 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) negative regulation of natural killer cell cytokine production(GO:0002728) |
0.0 | 0.3 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 1.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.4 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.0 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.0 | 0.0 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.4 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.3 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.4 | GO:0009584 | detection of visible light(GO:0009584) |
0.0 | 0.2 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.0 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.1 | GO:0006069 | ethanol oxidation(GO:0006069) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 10.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.5 | 4.4 | GO:0001534 | radial spoke(GO:0001534) |
1.0 | 11.0 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
1.0 | 4.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.7 | 2.0 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.6 | 1.7 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.5 | 4.3 | GO:1990357 | terminal web(GO:1990357) |
0.5 | 3.7 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.5 | 3.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.5 | 1.5 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.5 | 5.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 2.2 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.4 | 17.6 | GO:0030057 | desmosome(GO:0030057) |
0.4 | 0.4 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.4 | 1.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.4 | 1.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 1.7 | GO:0031905 | early endosome lumen(GO:0031905) |
0.3 | 4.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 1.0 | GO:0030689 | Noc complex(GO:0030689) |
0.3 | 2.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 2.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 3.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 8.4 | GO:0097386 | glial cell projection(GO:0097386) |
0.3 | 4.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 0.3 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.3 | 1.3 | GO:0016938 | kinesin I complex(GO:0016938) |
0.3 | 1.3 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.3 | 1.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.3 | 1.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.3 | 2.3 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.3 | 1.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 1.0 | GO:0060187 | cell pole(GO:0060187) |
0.2 | 1.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 1.3 | GO:0032044 | DSIF complex(GO:0032044) |
0.2 | 0.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 1.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.2 | 2.2 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 1.7 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 0.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 0.5 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 1.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 0.7 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 1.0 | GO:0031673 | H zone(GO:0031673) |
0.2 | 1.5 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.2 | 0.5 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.2 | 9.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.5 | GO:0097444 | spine apparatus(GO:0097444) |
0.2 | 1.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.6 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 13.0 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.8 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 2.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 1.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 6.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 2.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 3.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.3 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 4.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.8 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.7 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.5 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.1 | 2.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.8 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 5.3 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 3.2 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 1.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.9 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.2 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 0.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 11.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 1.3 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.3 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.1 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.8 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.7 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 1.0 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 1.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.5 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 2.9 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 1.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.4 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.1 | 1.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 1.3 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.2 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 1.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.0 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 2.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.7 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 1.6 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 1.5 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 1.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 2.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.4 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.1 | 1.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.9 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.5 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 1.8 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 1.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.8 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 2.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.4 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 0.6 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.2 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.1 | 1.1 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.2 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.5 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.1 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.1 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 1.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 2.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 0.3 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.1 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 4.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.1 | 0.5 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 2.7 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.7 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 2.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 1.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 1.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 2.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 1.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 1.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.2 | GO:0042025 | host cell nucleus(GO:0042025) |
0.1 | 0.5 | GO:0098793 | presynapse(GO:0098793) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.3 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 0.2 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.1 | 1.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.2 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.1 | 0.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 1.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 4.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 7.3 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 0.2 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 1.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.3 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.0 | 0.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 13.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.0 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.0 | 0.8 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 2.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.3 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.0 | 8.0 | GO:0016605 | PML body(GO:0016605) |
0.0 | 1.1 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
0.0 | 2.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.8 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.4 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 6.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.3 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 1.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.3 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 0.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.0 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 6.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 1.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 4.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 1.0 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 7.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 1.0 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.6 | GO:0032059 | bleb(GO:0032059) |
0.0 | 1.5 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.6 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 2.5 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 4.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 3.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.9 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 1.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 2.2 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.1 | GO:0031213 | RSF complex(GO:0031213) |
0.0 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.0 | 6.8 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 3.9 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.6 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 5.1 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.3 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 4.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 1.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 1.7 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 4.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.4 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.1 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.0 | 0.1 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
0.0 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.3 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 1.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 1.0 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 1.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.2 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 1.4 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 1.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.7 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.2 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
1.2 | 4.9 | GO:0070012 | oligopeptidase activity(GO:0070012) |
1.1 | 4.3 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
1.0 | 10.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.9 | 3.5 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.8 | 3.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.8 | 5.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.8 | 2.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.8 | 2.4 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.8 | 2.3 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.8 | 4.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.7 | 8.3 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.7 | 2.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.6 | 1.9 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.6 | 9.6 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.6 | 5.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.6 | 1.8 | GO:0004103 | choline kinase activity(GO:0004103) |
0.6 | 0.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.6 | 1.7 | GO:0032093 | SAM domain binding(GO:0032093) |
0.5 | 2.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.5 | 2.5 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.5 | 3.5 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.5 | 2.9 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.5 | 1.4 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.5 | 2.3 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.4 | 3.8 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.4 | 2.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.4 | 2.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.4 | 1.1 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.4 | 2.6 | GO:0046979 | TAP2 binding(GO:0046979) |
0.4 | 2.2 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 0.4 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.3 | 1.0 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.3 | 1.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 4.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 7.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 1.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 3.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 2.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 2.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.3 | 1.9 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.3 | 0.9 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 1.8 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.3 | 0.9 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.3 | 1.2 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.3 | 2.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 0.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 2.9 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 1.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.3 | 1.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 2.5 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.3 | 0.8 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.3 | 6.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 2.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 0.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 1.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 5.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.3 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.3 | 0.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 3.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 1.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.2 | 4.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 1.0 | GO:1902379 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
0.2 | 1.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 4.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 1.6 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 8.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 1.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 2.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.7 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.2 | 2.0 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 2.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.9 | GO:0001855 | complement component C4b binding(GO:0001855) |
0.2 | 1.3 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.2 | 0.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.2 | 1.9 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.2 | 0.6 | GO:0086079 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
0.2 | 0.9 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 2.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.2 | 1.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 2.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 1.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.6 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
0.2 | 1.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.6 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.2 | 1.9 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.2 | 1.0 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.2 | 0.6 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.2 | 1.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 2.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 3.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 0.8 | GO:1904492 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
0.2 | 2.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 1.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 0.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 1.6 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 0.5 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.2 | 6.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 8.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 0.4 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.2 | 2.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.7 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 0.7 | GO:1990175 | EH domain binding(GO:1990175) |
0.2 | 0.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 1.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 2.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 1.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 1.1 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 0.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.6 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.2 | 0.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.8 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 1.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 1.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 1.8 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 1.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 1.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.2 | 2.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 0.5 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.1 | 0.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.4 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
0.1 | 0.6 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.1 | 0.6 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.1 | 0.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 5.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.7 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 5.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.7 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 2.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 3.9 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 1.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.6 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 0.6 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 4.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 41.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.5 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.1 | 7.8 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.5 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.1 | 1.7 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.5 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.1 | 0.8 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.7 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.1 | 1.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 18.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 5.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 1.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 1.0 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.1 | 2.5 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 1.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.6 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.1 | 3.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 2.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 24.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.6 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
0.1 | 0.4 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 2.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 4.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.5 | GO:0031716 | calcitonin receptor activity(GO:0004948) calcitonin receptor binding(GO:0031716) |
0.1 | 0.7 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 4.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 3.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.2 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 1.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 1.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 2.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.9 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 2.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.3 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.1 | 2.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.5 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 1.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 1.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.4 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 6.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.9 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.5 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.1 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 0.4 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 1.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 1.6 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 1.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 1.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.2 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 0.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 2.5 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.3 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.1 | 2.8 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.9 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.1 | 4.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.4 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 3.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.6 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) steroid sulfotransferase activity(GO:0050294) |
0.1 | 2.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 1.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.7 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 1.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.2 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.1 | 0.4 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.1 | 0.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 1.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 1.2 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.5 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.1 | 0.4 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 1.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 2.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 1.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.6 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 0.7 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 3.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.4 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.1 | 1.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.6 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.1 | 0.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 5.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.5 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 1.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 3.0 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.4 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 0.9 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.6 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 3.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 2.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 1.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.3 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 3.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.1 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 2.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.9 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 1.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 1.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.3 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.2 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 0.2 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.1 | 0.5 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.1 | 0.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 1.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.3 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.1 | 1.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 1.6 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 1.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 1.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 12.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 0.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.2 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.1 | 3.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 1.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.2 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.1 | 0.3 | GO:0019959 | interleukin-8 receptor activity(GO:0004918) interleukin-8 binding(GO:0019959) |
0.1 | 0.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.4 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.1 | 1.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.3 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.0 | 0.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 11.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.1 | GO:0005503 | all-trans retinal binding(GO:0005503) |
0.0 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.5 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.2 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.0 | 0.2 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.0 | 0.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 1.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.2 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.0 | 1.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.2 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.0 | 0.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 6.0 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.2 | GO:0031751 | D2 dopamine receptor binding(GO:0031749) D4 dopamine receptor binding(GO:0031751) |
0.0 | 1.7 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.3 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.0 | 1.4 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 1.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.2 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.0 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 1.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
0.0 | 0.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.0 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.2 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.0 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 6.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.2 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.0 | 1.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
0.0 | 0.1 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.5 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.3 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.2 | GO:0030613 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 2.0 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.4 | GO:0030546 | receptor activator activity(GO:0030546) |
0.0 | 0.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.0 | 0.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.0 | 2.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.6 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 1.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.2 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.0 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 3.5 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.0 | 0.1 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.0 | 1.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 1.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 1.5 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 1.0 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.4 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.0 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.0 | 0.4 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 1.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 1.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.9 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 0.2 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.0 | 1.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.0 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.3 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.0 | 0.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.9 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.1 | GO:0008193 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.0 | 0.7 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.1 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.1 | GO:0004797 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
0.0 | 1.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 2.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 4.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.4 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.4 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 3.8 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.0 | 0.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.2 | GO:0016896 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.3 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.0 | 0.1 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 0.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.0 | 0.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 10.8 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 1.0 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.0 | 0.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.0 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 0.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 5.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 0.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 1.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 6.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 4.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 5.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 2.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 4.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 8.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 2.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 4.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 2.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 2.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 5.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 25.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 1.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 6.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 2.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 6.6 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 2.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 2.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 2.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 4.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 6.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 2.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 3.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 2.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 2.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 4.1 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 1.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 1.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 10.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 2.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 1.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 3.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.9 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 2.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 2.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 1.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 1.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 2.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.2 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.2 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 1.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.5 | 1.5 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.3 | 2.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.3 | 8.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.3 | 4.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 2.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 8.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 5.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 5.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 4.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 4.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.2 | 2.9 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 8.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 9.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 0.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 3.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 12.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 7.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 5.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 1.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 5.8 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.1 | 2.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 3.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.5 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 1.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 2.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 1.1 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.1 | 2.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 10.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 1.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 2.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 0.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 7.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 1.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 1.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 3.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 1.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 3.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 3.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 3.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 1.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 1.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.2 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 1.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 1.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 1.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.4 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 3.7 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.5 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.0 | 2.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.3 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.6 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 6.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 2.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 1.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.7 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 2.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 2.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 1.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 1.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.1 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 2.3 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |